Gracell Biotechnologies Reports Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results and Provides Corporate Update
Go back to Gracell Biotechnologies Reports Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results and Provides Corporate Update(NASDAQ: GRCL) | Delayed: 10.25 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $10.25 | 52 Week High | $ | |||
Open | $10.25 | 52 Week Low | $ | |||
Day High | $10.25 | P/E | N/A | |||
Day Low | $10.25 | EPS | $ | |||
Volume | 1 |